Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
+22.7%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.07% |
| Q3 2025 | -17.47% |
| Q2 2025 | -0.22% |
| Q1 2025 | -0.28% |
| Q4 2024 | -0.21% |
| Q3 2024 | -0.20% |
| Q2 2024 | -0.20% |
| Q1 2024 | -0.19% |
| Q4 2023 | -0.17% |
| Q3 2023 | -0.17% |
| Q2 2023 | -0.17% |
| Q1 2023 | -0.16% |
| Q4 2022 | -0.03% |
| Q3 2022 | -0.14% |
| Q2 2022 | -0.15% |
| Q1 2022 | 56.03% |
| Q4 2021 | 0.76% |
| Q3 2021 | 1.40% |
| Q2 2021 | 2.41% |
| Q1 2021 | 2.60% |
| Q4 2020 | 1.10% |
| Q3 2020 | 14.93% |
| Q2 2020 | 1.25% |
| Q1 2020 | 1.25% |
| Q4 2019 | 1.24% |
| Q3 2019 | 1.23% |
| Q2 2019 | -9.14% |
| Q1 2019 | 1.13% |
| Q4 2018 | 1.12% |
| Q3 2018 | 373.84% |
| Q2 2018 | 0.36% |
| Q1 2018 | 0.36% |
| Q4 2017 | 0.37% |
| Q3 2017 | 0.37% |
| Q2 2017 | 0.37% |
| Q1 2017 | 0.36% |
| Q4 2016 | 0.37% |
| Q3 2016 | 0.37% |
| Q2 2016 | 0.37% |
| Q1 2016 | 0.06% |